Diabetes Pipeline Landscape Research Report 2024: Comprehensive Insights About 200+ Companies and 200+ Pipeline Drugs
21. November 2024 04:09 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetes - Pipeline Insight, 2024" report...
Type 2 Diabetes Pipeline Landscape Research 2024: Comprehensive Insights About 75+ Companies and 80+ Drugs
21. November 2024 04:04 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Dementia with Diabetes Pipeline Therapeutics Market Report 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
17. Juli 2024 09:09 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
26. November 2021 07:53 ET
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
Dementia with Diabetes Pipeline Insight Report, 2020 - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
04. November 2020 07:03 ET
|
Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Dementia with Diabetes -...